Commonwealth Equity Services’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Sell
20,132
-2,359
-10% -$308K ﹤0.01% 2016
2025
Q4
$2.74M Buy
22,491
+3,587
+19% +$450K ﹤0.01% 1752
2025
Q3
$2.12M Buy
18,904
+240
+1% +$28.1K ﹤0.01% 1949
2025
Q2
$2.5M Buy
18,664
+4,575
+32% +$502K ﹤0.01% 1820
2025
Q1
$948K Buy
14,089
+4,184
+42% +$288K ﹤0.01% 2501
2024
Q4
$618K Buy
9,905
+1,460
+17% +$136K ﹤0.01% 2789
2024
Q3
$1.33M Buy
8,445
+1,948
+30% +$300K ﹤0.01% 2112
2024
Q2
$979K Buy
6,497
+2,491
+62% +$299K ﹤0.01% 2300
2024
Q1
$296K Buy
4,006
+544
+16% +$44.8K ﹤0.01% 3290
2023
Q4
$273K Buy
+3,462
New +$209K ﹤0.01% 3248

Other funds holding TMDX

Commonwealth Equity Services's TMDX Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Transmedics (TMDX) stake by 10% in Q1 2026, selling an estimated $308K and leaving 20,132 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

Commonwealth Equity Services first reported a position in TMDX in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.74M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Commonwealth Equity Services held 20,132 shares of Transmedics worth $2M as of Q1 2026.
  • Commonwealth Equity Services sold 2,359 Transmedics shares in Q1 2026, an estimated $308K.
  • Transmedics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #2016 holding.
  • Commonwealth Equity Services first reported a position in Transmedics in Q4 2023 and has held it in 10 quarters since.
  • Commonwealth Equity Services's Transmedics position peaked at $2.74M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.